期刊文献+

脑脊液端粒酶检测在脑肿瘤诊断中的意义 被引量:1

Signification of telomerase activity in cerebrospinal fluid specimens for distinguishing benign and malignant meningeal carcinomatosis
下载PDF
导出
摘要 目的 检测端粒酶在脑部肿瘤的表达情况。方法 应用高灵敏度的以 PCR技术为基础的端粒重复扩增实验 ( TRAP)定量测定了 4 8份脑脊液标本的端粒酶水平 ,其中包括神经系统疾病患者和非神经系统疾病患者。结果 脑脊液端粒酶检测对于脑脊液恶变细胞的诊断特异性和灵敏度分别为 95 %和 72 %。结论 运用TRAP方法检测脑脊液端粒酶是对传统脑脊液细胞学检查的一个重要补充 ,在鉴别诊断良。 Objective Telomerase does not express in the normal human body cell but has high activities in most of the carcinomas derived from various organs.The author tried to gain a clear idea of telomerase as a tumor marker in the earlier diagnosis of malignant neoplasia.Method Telomerase activities in 48 samples of cerebrospinal fluid (CSF),including neurologic and non neurologic patients were analysed using a sensitive polymerase chain reaction based assay,ie,the telomeric repeat amplification protocol (TRAP).Results An adjusted specificity of 95% and a sensitivity of 72% were achieved for detecting malignant cells in CSF.Conclusion The TRAP assay for telomerase detection may serve as an adjunct to the traditional examination of CSF and show a unique superiority and practicability in the differential diagnosis of benign and malignant meningeal carcinomatosis.
机构地区 山西省人民医院
出处 《山西医药杂志》 CAS 2001年第5期393-395,共3页 Shanxi Medical Journal
关键词 端粒酶 端粒 端粒重复扩增实验 脑肿瘤 脑脊液 Telomerase Telomere Telomeric repeat amplification protocol Meningeal carcinomatosis
  • 相关文献

参考文献14

  • 1[1]Kontogeorgos G,Kovacs K.Telomeres and telomerase in endocrine pathology.Endocrin,1998,9(2):133-138.
  • 2[2]Kiyozuka LM.Telomere length,telomerase activity and telomerase RNA expression during mouse mammary tumor progression.Int J Mol Med,1998,2(4):437-444.
  • 3[3]Brousset P.Telomerase activity might persist in the human thymus throughout life.Mol Pathol,1998,51(3):170-173.
  • 4[4]Soria JC,Vielh P,el Naggar AK.Telomerase activity in cancer:a magic bullet or a mirage?Adv Anat Pathol,1998,5(2):86-94.
  • 5[5]Schalken J.Molecular diagnostics and therapy of prostate cancer:a new avenues.Eur Urol,1998,34(Suppl 3):3-6.
  • 6[6]Ohysdhiki K.A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.Cancer,1997,83(12):2554-2560.
  • 7[7]Li H,Zhao L,Yang-Zfunder JW,et al.Telomerase is controlled by protein kinase alpha in human breast cancer cells.J Biol Chem,1998,273(50):33436-33442.
  • 8[8]Ogama Y,Nishioka A,Hamada N,et al.Changes in telomerase activity of advanced cancers of oral cavity and oropharynx during radiation therapy:correlation with clinical outcome.Int J Mol Med,1998,2(3):301-307.
  • 9[9]Hiyama K.Telomerase activity as a novel marker of lung cancer and immune-associated lung diseases.Int J Mol Med,1998,1(3):545-549.
  • 10[10]Park YM.Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.Exp Mol Med,1998,30(1):35-40.

同被引文献19

  • 1苏保鑫,顾薇薇,李淑翠,王金玲,张田玲,李庆.端粒酶检测对恶性胸腹水的诊断价值探讨[J].医学检验与临床,2006,18(3):57-58. 被引量:1
  • 2朱萱,李弼民,陈兴玲,张昆和,陈江,张小茜.胰液细胞学及肿瘤相关标志物联合检测在胰腺癌诊断中的价值[J].江西医药,2006,41(6):343-345. 被引量:2
  • 3闫骏,袁亚光.晨尿脱落细胞端粒酶活性检测在膀胱癌中的诊断价值[J].内蒙古医学杂志,2007,39(5):525-527. 被引量:3
  • 4Tamm EP, Silverman PM, Charnsangavej C, et al. Diag- nosis, staging, and surveillance of pancreatic cancer [J]. AJR Am J Roentgenol,2003,180(5): 1311-1323.
  • 5Rashid-Kolvear F, Taboski MA, Nguyen J, et al. Trogl- itazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells[J]. BMC Cancer, 2010,10(1) : 390.
  • 6Hackett JA, Greider CW. Balancing instability: dual roles for telomerase and telomere dysfunction in tu- morigenesis[J]. Oncogene, 2002,21 (4) : 619-626.
  • 7Blackburn EH. Telomere states and cell fates[J]. Na- ture,2000,408(6808) :53-56.
  • 8Stonesifer KJ, Xiang JH, Wilkinson EJ, et al. Flow cy- tometric analysis and cytopathology of body cavity flu- ids[J]. Acta Cytol, 1987,31(2) : 125-130.
  • 9Melissourgos N, Kastrinakis NG, Davilas I, et al. De- tection of human telomerase reverse transcriptase mR- NA in urine of patients with bladder cancer: evaluation of an emerging tumor marker[J]. Urology, 2003, 62 (2) :362-367.
  • 10Campbell PM, Groehler AL, Lee KM, et al. K-Ras promotes growth transformation and invasion of im- mortalized human pancreatic cells by Raf and phos- phatidylinositol 3-kinase signaling [J]. Cancer Res, 2007,67 (5) : 2098-2106.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部